Depletion of BIS sensitizes A549 cells to treatment with cisplatin

[1]  P. Chu,et al.  Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing. , 2016, Biomaterials.

[2]  G. Bartsch,et al.  Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737 , 2016, World Journal of Urology.

[3]  D. Tuveson,et al.  BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages , 2015, Nature Communications.

[4]  G. Kroemer,et al.  Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells , 2015, Cell Death and Disease.

[5]  E. Wagner,et al.  Peptide-like Polymers Exerting Effective Glioma-Targeted siRNA Delivery and Release for Therapeutic Application. , 2015, Small.

[6]  Shufeng Zhou,et al.  Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer , 2015, Drug design, development and therapy.

[7]  Jeong-Hwa Lee,et al.  Bis Expression in Patients with Surgically Resected Lung Cancer and its Clinical Significance , 2015, Annals of Surgical Oncology.

[8]  Jeong-Hwa Lee,et al.  Bis is Induced by Oxidative Stress via Activation of HSF1 , 2014, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

[9]  R. Franco,et al.  The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth , 2014, Oncotarget.

[10]  Z. Zong,et al.  BAG3 promoted starvation-induced apoptosis of thyroid cancer cells via attenuation of autophagy. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  Yun‐Sil Lee,et al.  2,4-Bis(4-hydroxybenzyl)phenol inhibits heat shock transcription factor 1 and sensitizes lung cancer cells to conventional anticancer modalities. , 2014, Journal of natural products.

[12]  Z. Zong,et al.  BAG3 sensitizes cancer cells exposed to DNA damaging agents via direct interaction with GRP78. , 2013, Biochimica et biophysica acta.

[13]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[14]  Z. Zong,et al.  PKCδ-mediated phosphorylation of BAG3 at Ser187 site induces epithelial−mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells , 2013, Oncogene.

[15]  M. Caraglia,et al.  BAG3 Is a Novel Serum Biomarker for Pancreatic Adenocarcinomas , 2013, The American Journal of Gastroenterology.

[16]  L. Marnett,et al.  The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737* , 2013, Journal of Biological Chemistry.

[17]  R. Franco,et al.  Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. , 2012, The American journal of pathology.

[18]  P. Liu,et al.  BAG3: a new therapeutic target of human cancers? , 2012, Histology and histopathology.

[19]  Q. Lu,et al.  Bag3 promotes resistance to apoptosis through Bcl-2 family members in non-small cell lung cancer. , 2011, Oncology reports.

[20]  Shu-Bing Qian,et al.  Chaperone-mediated hierarchical control in targeting misfolded proteins to aggresomes , 2011, Molecular biology of the cell.

[21]  C. Behl.  BAG3 and friends: Co-chaperones in selective autophagy during aging and disease , 2011, Autophagy.

[22]  R. Franco,et al.  BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. , 2011, The American journal of pathology.

[23]  V. de Laurenzi,et al.  BAG3: a multifaceted protein that regulates major cell pathways , 2011, Cell Death and Disease.

[24]  D. Han,et al.  KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to the hsp70 Promoter* , 2010, The Journal of Biological Chemistry.

[25]  Jeong-Hwa Lee,et al.  Down-modulation of Bis sensitizes cell death in C6 glioma cells induced by oxygen–glucose deprivation , 2010, Brain Research.

[26]  L. Moretti,et al.  AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  L. Marnett,et al.  HSF1-mediated BAG3 Expression Attenuates Apoptosis in 4-Hydroxynonenal-treated Colon Cancer Cells via Stabilization of Anti-apoptotic Bcl-2 Proteins* , 2009, Journal of Biological Chemistry.

[28]  Bao-qin Liu,et al.  Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1 , 2009, Journal of cellular physiology.

[29]  P. Liu,et al.  BAG3 gene silencing sensitizes leukemic cells to Bortezomib‐induced apoptosis , 2009, FEBS letters.

[30]  Susanna M Cramb,et al.  The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Johan Vansteenkiste,et al.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Turco,et al.  bag3 gene expression is regulated by heat shock factor 1 , 2008, Journal of cellular physiology.

[33]  Ping Yang,et al.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.

[34]  M. Todaro,et al.  The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. , 2007, The Journal of clinical endocrinology and metabolism.

[35]  Robert Gray,et al.  Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. , 2006, The New England journal of medicine.

[36]  D. Allison,et al.  Chromosomal Variations Within Aneuploid Cancer Lines , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[37]  S. Venuta,et al.  BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis , 2003, Cell Death and Differentiation.

[38]  David Harrington,et al.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. , 2002, The New England journal of medicine.

[39]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[40]  S. Edwards,et al.  In vivo localisation and stability of human Mcl‐1 using green fluorescent protein (GFP) fusion proteins , 2000, FEBS letters.

[41]  Y. Tsujimoto,et al.  Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death , 1999, Oncogene.

[42]  Shufeng Zhou,et al.  small-molecule Bh 3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of aPe 1 repair and redox activity in non-small-cell lung cancer , 2015 .

[43]  H. Mei,et al.  Autophagy inhibition enhances pan-Bcl-2 inhibitor AT-101-induced apoptosis in non-small cell lung cancer. , 2014, Neoplasma.

[44]  A. Jemal,et al.  Global Cancer Statistics , 2011 .